ErbB2 (Her-2/Neu, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, p185erbB2, p185HER2)

Catalogue Number: 361584-USB

Manufacturer:United States Biological
Physical state:Supplied as a liquid in PBS, pH 7.2, 0.02% Proclin-300.
Type:Monoclonal Primary Antibody - Unconjugated
Shipping Condition:Blue Ice
Unit(s): 200 ug
Host name: Human
Clone: 4D5-8 (trastuzumab) (recomb)
Isotype: IgG1, kappa
Immunogen: A431 cells (human epidermoid carcinoma) (over)expressing EGFR.
Application: ELISA, FC, IHC

Description

Description: Recombinant monoclonal antibody to ErbB2 with variable regions (i.e. specificity) from the therapeutic antibody 4D5-8 (trastuzumab). Manufactured using a proprietary recombinant platform technology. Not for therapeutic use; this is a research grade biosimilar. Oncogenic protein Her-2/neu (erbB-2), is a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder. This antibody binds to erbB-2/Her-2/neu has therapeutic indications particularly in the treatment of breast cancer (c.f. Herceptin). It can also be used to detect HER-2 by flow cytometry or IHC.

Additional Text

Gene ID

2064

Gene Name

ERBB2

Uniprot ID

P04626

Specificity

Recognizes ErbB-2. Species Crossreactivity: human

Purification

Protein A purified

Antibody Clonality

Recombinant Monoclonal